Pre-pectoral vs Sub-pectoral Implant Placement for Breast Reconstruction
Trial Summary
What is the purpose of this trial?
This trial compares two methods of breast implant placement after mastectomy to see which causes less pain and has better outcomes. It targets women having breast reconstruction and uses a special supportive tissue in both methods.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of this treatment for breast reconstruction?
Research suggests that prepectoral implant placement with acellular dermal matrix (ADM) can offer better cosmetic results and less pain compared to subpectoral placement, as it avoids muscle injury and related complications. Studies have shown that this method is gaining popularity due to its advantages, such as reduced postoperative pain and avoidance of breast animation deformities.12345
Is prepectoral or subpectoral implant placement for breast reconstruction safe?
Both prepectoral and subpectoral implant placements for breast reconstruction have been studied for safety. Prepectoral placement with acellular dermal matrix (ADM) has shown improved pain scores and faster recovery compared to subpectoral placement, with an appropriate safety profile. However, there is limited evidence comparing the two directly, and some studies suggest potential complications with ADM use.12367
How does pre-pectoral implant placement differ from sub-pectoral implant placement in breast reconstruction?
Pre-pectoral implant placement involves placing the implant above the chest muscle, which can reduce pain and avoid muscle-related complications like animation deformity (unwanted movement of the breast when the muscle contracts). This method uses acellular dermal matrix (ADM) to support the implant, potentially offering better cosmetic results compared to the traditional sub-pectoral placement, where the implant is placed under the chest muscle.12589
Research Team
Jing Zhang, MD
Principal Investigator
Ottawa Hospital Research Institute
Eligibility Criteria
This trial is for women aged 20-80 who are undergoing mastectomy due to breast cancer or as a preventive measure and can consent to the study. It's not for those with immediate reconstruction contraindications, smokers, BMI over 40, prior chest radiation, or large breast size/grade III ptosis.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Immediate acellular dermal matrix-assisted implant-based breast reconstruction with either prepectoral or subpectoral implant placement
Follow-up
Participants are monitored for postoperative pain, complications, and patient-reported outcomes
Data Analysis and Dissemination
Data collection, analysis, and dissemination of results
Treatment Details
Interventions
- Immediate acellular dermal matrix-assisted implant-based breast reconstruction with prepectoral implant placement
- Immediate acellular dermal matrix-assisted implant-based breast reconstruction with subpectoral implant placement
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ottawa Hospital Research Institute
Lead Sponsor